Alzheimer’s & Dementia Archives | Experience Life https://experiencelife.lifetime.life/category/health/health-conditions/alzheimers-dementia/ Wed, 01 Oct 2025 14:35:48 +0000 en-US hourly 1 https://wordpress.org/?v=6.8.2 Aging With Brain Power: How to Boost Your Mental Acuity and Cognition (Performance & Longevity Series) https://experiencelife.lifetime.life/podcast/aging-with-brain-power-how-to-boost-your-mental-acuity-and-cognition-performance-longevity-series/ Thu, 02 Oct 2025 10:00:04 +0000 https://experiencelife.lifetime.life/?post_type=podcast&p=124563 The post Aging With Brain Power: How to Boost Your Mental Acuity and Cognition (Performance & Longevity Series) appeared first on Experience Life.

]]>

The post Aging With Brain Power: How to Boost Your Mental Acuity and Cognition (Performance & Longevity Series) appeared first on Experience Life.

]]>
jim headshot
Breaking Insulin Resistance: Your Guide to Blood-Sugar Mastery (Performance & Longevity Series) https://experiencelife.lifetime.life/podcast/breaking-insulin-resistance-your-guide-to-blood-sugar-mastery-performance-longevity-series/ Thu, 07 Aug 2025 10:00:40 +0000 https://experiencelife.lifetime.life/?post_type=podcast&p=121297 The post Breaking Insulin Resistance: Your Guide to Blood-Sugar Mastery (Performance & Longevity Series) appeared first on Experience Life.

]]>

The post Breaking Insulin Resistance: Your Guide to Blood-Sugar Mastery (Performance & Longevity Series) appeared first on Experience Life.

]]>
Jim headshot and woman tracking food
PUMPING IRONY: Hard Times on the Alzheimer’s Front https://experiencelife.lifetime.life/article/pumping-irony-hard-times-on-the-alzheimers-front/ https://experiencelife.lifetime.life/article/pumping-irony-hard-times-on-the-alzheimers-front/#view_comments Tue, 05 Nov 2024 18:00:22 +0000 https://experiencelife.lifetime.life/?post_type=article&p=107181 The Big Pharma approach to treating Alzheimer’s has met with some serious obstacles in recent months, a trend that may encourage more nuanced treatment protocols.

The post PUMPING IRONY: Hard Times on the Alzheimer’s Front appeared first on Experience Life.

]]>

These are not the best of times for the Big Pharma players betting the house on Alzheimer’s drugs. Dismal demand, controversial trial methods, and alleged ethical breaches have largely dissipated whatever enthusiasm these companies had generated among dementia sufferers — not to mention Wall Street investors. And the trend has some researchers looking beyond pharmaceuticals in their search for a cure.

The rise and fall of Aduhelm, which Biogen pulled from the market earlier this year, has been well documented, but the symptoms leading to its demise seem to be contagious. Leqembi, a collaboration between Biogen and Eisai, entered the Alzheimer’s sweepstakes last year only to confront similar marketplace obstacles: Only a small portion of dementia patients qualify for the treatment, the out-of-pocket expense (as much as $6,600 annually) is prohibitive, and the regimen (biweekly infusions, frequent MRI scans) can be daunting. All this for the vague possibility that the drug may slow the advance of the disease by about five months.

Then there are the side effects. The drugs have been shown in clinical trials to cause brain swelling and bleeding — particularly among participants most genetically susceptible to Alzheimer’s. Indeed, As The New York Times reported recently, more than one in three patients carrying two copies of the APOE4 gene experienced brain bleeding or swelling during the Leqembi trial.

And both Eisai and Eli Lilly have come under fire by medical ethicists for their clinical trial practices. Although they test participants to determine whether they carry the APOE4 gene prior to the trial, they don’t tell them the results because, researchers argue, it may affect how they rate their progress. Dozens of volunteers have subsequently suffered “severe” brain bleeding after infusions; a handful have died.

“Researchers unfortunately have an inherent conflict of interest,” Robert Klitzman, MD, director of the Masters of Bioethics Program at Columbia University, tells the Times. “They want people to be in their study, and there are researchers who feel, if I tell people the full facts and risks, they may not want to be in the study.”

Meanwhile, the Securities and Exchange Commission (SEC) in September brought charges against Cassava Sciences for allegedly publishing misleading research results of its simufilam drug trials. A federal grand jury indicted the company’s lead researcher, Hoau-Yan Wang, PhD, for falsifying study data, much of his published research has been retracted, and he was placed on administrative leave from the City University of New York. Cassava’s CEO and his wife, a lead scientist, have resigned.

The company and the SEC eventually agreed to a $40 million settlement, but simufilam remains, implausibly, poised for government approval.

Phase 3 clinical trials, involving some 1,900 patients, are reportedly ongoing, and officials at the Food and Drug Administration tell the Times they “may take appropriate action” if a detailed review reveals any false data.

It’s the prevalence of such chaos that seems to be nudging an increasing number of scientists toward a new approach to fighting the disease. Big Pharma’s obsession with amyloid-lowering drugs — when it’s been shown that the plaque doesn’t always appear in Alzheimer’s patients — is muddying the research waters, notes Matthew Schrag, MD, PhD, a Vanderbilt University neurologist. “While beta amyloid may play a role in Alzheimer’s disease,” he says, “it’s not the central disease driver, and we need a more nuanced understanding of this disease if we’re going to be successful in really moving the ball.”

That might mean more focus on such mundane issues as sleep quality, regular exercise, and eating habits. Or, as Tarek Rajji, MD, argues, it might mean exploring a combo of cognitive therapy and transcranial direct current stimulation (tDCS), a type of noninvasive brain stimulation.

Rajji, a psychiatry professor at the University of Texas Southwestern Medical Center, and his team of researchers recruited 375 older adults and divided them into two groups; one group received a combination of cognitive therapeutic treatment (puzzles and logic problems) along with tDCS, while the control group was given a “sham” intervention. The five-days-a-week sessions lasted for eight weeks and included five-day “booster” sessions every six months over the course of four years. Researchers then tracked the volunteers’ cognitive performance for another three years.

The results, published last week in JAMA Psychiatry, may offer some hope in the midst of Big Pharma chaos. “We are very pleased to show, after seven years of close monitoring, that this combination of therapies is effective in slowing down cognitive decline for some of our most vulnerable populations,” Rajji said in a statement. “This study shows promise that the multiprong, nonpharmacological approaches for people with a high risk of developing dementia could help them live a more independent life for a longer time.”

I suspect such findings aren’t going to nudge Eisai, Biogen, Lilly, Cassava, and their Big Pharma brethren from the Alzheimer’s battlefield anytime soon. Despite the current setbacks, these researchers simply don’t know any other way to address the disease. It’s just the way they think. Perhaps they should undergo a little brain stimulation.

The post PUMPING IRONY: Hard Times on the Alzheimer’s Front appeared first on Experience Life.

]]>
https://experiencelife.lifetime.life/article/pumping-irony-hard-times-on-the-alzheimers-front/feed/ 0 medical illustration.
What Can I Do to Lower My Alzheimer’s Risk and Dementia? https://experiencelife.lifetime.life/article/what-can-i-do-to-lower-my-alzheimers-risk-and-dementia/ Wed, 25 Sep 2024 07:55:18 +0000 https://experiencelife.lifetime.life/?post_type=article&p=103405 Neurologist David Perlmutter, MD, shares nine strategies for preventing cognitive decline.

The post What Can I Do to Lower My Alzheimer’s Risk and Dementia? appeared first on Experience Life.

]]>

After years of hope and hype, finding a cure for Alzheimer’s disease and other types of dementia seems as distant as ever. The true breakthroughs have come in ways to deter the disease, and some scientists view prevention as the best prospect for defeating it.

“We’ve got to take care of our brains every single day,” says neurologist David Perlmutter, MD, FACN, ABIHM, author of the New York Times bestsellers Grain Brain: The Surprising Truth About Wheat, Carbs, and Sugar — Your Brain’s Silent Killers and Brain Maker: The Power of Gut Microbes to Heal and Protect Your Brain — for Life. “We are the architects of our brain’s destiny in that we absolutely control our brain’s health via the lifestyle choices that we make each and every day.” (Visit “Overcoming Grain Brain” for more.)

Alzheimer’s disease begins 20 years or more before memory loss and other symptoms develop, according to the Alzheimer’s Association’s 2024 Alzheimer’s Disease Facts and Figures report. “Alzheimer’s disease is a type of brain disease, just as coronary artery disease is a type of heart disease. It is caused by damage to nerve cells (neurons) in the brain,” the report authors explain. “In Alzheimer’s disease, the neurons damaged first are those in parts of the brain responsible for memory, language, and thinking, which is why the first symptoms tend to be memory, language, and thinking problems.”­

In a recent issue of the Lancet focused on dementia prevention, an executive summary stated that about 40 percent of worldwide dementias are potentially preventable. But other scientists disagree: They believe the number could be far larger.

“I believe that 80 to 90 percent of prospective cases can be substantially delayed or prevented,” writes neuroscientist Michael Merzenich, PhD, professor emeritus of the University of California, San Francisco, in a 2023 Medscape commentary.

The key to prevention? Living a fit and healthy lifestyle, says Perlmutter.

A New Look at Alzheimer’s Pathology

The focus on prevention comes in part due to a revised understanding of what causes Alzheimer’s. It was long believed that amyloid beta-protein plaque in the brain triggered neurodegeneration by strangling brain nerve cells: The plaque was thought to cause tangles made of another protein, called tau, within the nerves.

Battling amyloid became the nexus of research, and thus funding, into pharmaceuticals and cures for Alzheimer’s — to the detriment of other research avenues, Perlmutter says. But this explanation of Alzheimer’s pathology came under suspicion following 2022 reports of fraudulent past ­research, as well as other findings.

Now, many experts are shifting the focus away from amyloid plaques and toward metabolism. “What makes a good brain go bad ultimately turns out to be a metabolic change,” Perlmutter explains. “It is a bioenergetic issue: a failure of the brain’s ability to supply blood to itself and to use the fuel in that blood, which is glucose, to power itself.”

A 2017 review published in Frontiers in Aging Neuroscience details the metabolic failure and connection between Alzheimer’s Disease and insulin resistance. It highlights research that finds brain-glucose hypometabolism, or decreased brain-glucose consumption, may occur decades before clinical manifestations of Alzheimer’s.

In addition, the authors report that people with insulin resistance or type 2 diabetes have an increased risk of developing the disease (listen as Jim LaValle, RPh, CCN, explains the factors that contribute to insulin resistance, how to measure and monitor blood sugar, and the habits we can adopt to manage blood sugar effectively at “Breaking Insulin Resistance: Your Guide to Blood-Sugar Mastery“).

“Now, using PET [positron emission tomography] scans and even more recently MRI [magnetic resonance imaging], we can detect and predict who’s going to have Alzheimer’s based on the loss of energy utilization — even when there’s no clinical issue like memory failure,” says Perlmutter.

With a better understanding of Alzheimer’s pathology, scientists could better focus on a preventive prescription.

The Importance of a Healthy Lifestyle

The link between lifestyle and memory decline in older adults became even clearer thanks to a 10-year cohort study published in the BMJ in 2023 that followed 29,072 people (46 percent of whom identified as female). “Our results show that a healthy lifestyle was associated with a slower rate of memory decline in cognitively normal older individuals, including in people who are genetically susceptible to memory decline,” the authors report.

“We found that diet had the strongest association with memory, followed by cognitive activity, physical exercise, and social contact. Although each lifestyle factor contributed differentially to slowing memory decline, our results showed that participants who maintained more healthy lifestyle factors had a significantly slower memory decline than those with fewer healthy lifestyle factors.”

Among those the study followed were people who carried the so-called Alzheimer’s gene, APOE4. “This means that the gene is really less important than we had thought,” Perlmutter explains. “Carrying the APOE4 allele does not condemn an individual to cognitive decline; lifestyle is so important.”

9 Strategies for Reducing the Risk of Dementia

The best preventive measures remain fundamental, says Perlmutter: Eat well, move your body, and exercise your brain. But the latest research has added some other items to this list.

1) Eat well.

What you eat does more than just fuel your body: It fuels your brain as well, and in multiple ways.

To start with, people with cardiovascular risk factors — type 2 diabetes, hypertension, and metabolic obesity — also have an increased risk of Alzheimer’s. This reinforces the benefits of a plant-based diet that includes plenty of healthy fats and fiber and is low in sugar and simple and refined carbohydrates.

Keeping your microbiome healthy with quality whole foods is critical, says Perlmutter. Eating too much sugar, too many simple carbohydrates, and too little fiber or healthy fats can fuel bad gut bacteria. Fermented foods, like sauerkraut, pickles, and yogurt with probiotic bacteria, as well as prebiotic fibers, are essential because they feed good gut bacteria.

“When a woman is pregnant, we say, ‘You have to be careful because you’re eating for two.’ But actually, each and every one of us is eating for the hundred trillion bacteria in our guts,” he explains. “Everything you eat either nurtures or damages your microbiome, so you really want to focus on avoiding things that are going to damage the microbiome.”

Perlmutter recommends choosing organic and non-GMO foods whenever possible because pesticides, herbicides, and other toxins can harm that bacterial habitat.

To protect and enhance the brain’s metabolic health, we need to ensure an adequate blood supply and the efficient utilization of glucose, he adds.

“Central to this is a gas … in the brain and the body called nitric oxide. Nitric oxide does two things: It improves glucose utilization by enhancing how insulin works, and it improves blood supply via vascular perfusion,” he explains. “Nitric oxide is a powerful mechanism helping exercise do its beautiful thing in our bodies. Exercise increases our ability to use glucose and improves blood supply.”

A 2018 study in Frontiers in Physiology examined the importance of nitric oxide as it relates to Alzheimer’s. “When we look at nitric oxide availability, we see a strong correlation of reduction in blood flow with reduction in nitric oxide bioavailability in the brain as we age — but worse, as it relates to the development of end-stage Alzheimer’s,” Perlmutter says.

Our bodies make nitric oxide in two ways. The first way is that cells in the endothelium — the thin layer of muscle lining blood vessels — produce nitric oxide from the amino acid L-arginine, which we can get from nuts and meat.

The second way is by processing nitrates from food, which are converted by bacteria in our mouths or stomachs into nitrites and then into nitric oxide. Foods rich in nitrates include colorful vegetables — think beets, garlic, fennel, arugula, radishes, and leafy greens such as spinach, arugula, chard, kale, and parsley — as well as meats, dark chocolate, citrus fruits, pomegranates, watermelon, nuts and seeds, and red wine.

Perlmutter is starting a study using nitric oxide to target the brain metabolism of people with Alzheimer’s.

2) Move your body.

Exercise has been hailed as a key to keeping our bodies and brains healthy. In fact, building muscles and conditioning your heart and circulatory system are side effects — exercise is really about your brain. Physical activity builds your gray matter in myriad ways, keeping it healthy while also making you more alert, creative, motivated, and perceptive.

“Our muscles are an endocrine organ, secreting chemicals that work throughout the body,” Perlmutter explains. “We activate that endocrine organ when we exercise, and the muscles create myokines — chemicals, or cytokines, synthesized and released by muscle cells during muscular contractions that are the molecular mediators of the great things that happen to our body and our brain when we exercise.”

The concept of the “myokinome” sums up the activity of all the myokines, which regulate the brain’s metabolism. Myokines include interleukin-6 (IL-6), ketone bodies, lactate, irisin, cathepsin-B, and brain-derived neurotrophic factor (BDNF).

Among these, IL-6 increases our ability to use glucose and blood sugar, break down fats and muscle, and use fatty acids. It does all this — while helping our metabolism — by triggering AMP-activated protein kinase, a pathway that allows us to use fat as a fuel and to grow new mitochondria, the energy powerplants within our cells — including within our brain cells. (Learn more about mitochondria at “The Care and Feeding of Your Mitochondria.”)

“We’re now looking at the notion of proper muscle-to-brain signaling as an important mechanism relating to brain health,” says Perlmutter. “When we don’t utilize this process, we may set ourselves up for brain disease.”

So how much exercise do you need to help your brain? A 2022 study in JAMA Neurology followed 78,430 adults with dementia for nearly seven years. “Our findings suggest that approximately 9,800 steps per day may be optimal to lower the risk of dementia,” the authors report.

But more importantly, the study “found no minimal threshold for the beneficial association of step counts with incident dementia.” In other words, any exercise is good, and more is better.

3) Exercise your brain.

Help keep your brain sharp by learning new things and staying socially active. There are several reasons to do this, and although they are currently theoretical, studies are under way.

The cognitive-reserve hypothesis holds that the more you learn, the more neuronal connections you make in your brain. These serve as a sort of brain trust as you age and compensate for the loss of other cells, so you can afford to lose more neurons before you show clinical symptoms of Alzheimer’s.

“Studies have shown that progression to AD or other dementias is driven primarily by the progressive deterioration of organic brain health, expressed by the loss of what psychologists have termed ‘cognitive reserve,’” Merzenich explains in his 2023 Medscape commentary.  “Cognitive reserve is resilience arising from active brain usage, akin to physical resilience attributable to a physically active life. Scientific studies have shown us that an individual’s cognitive resilience (reserve) is a greater predictor of risk for dementia than are amyloid plaques — indeed, greater than any combination of pathologic markers in dementia patients.”

Brain games like Sudoku and bridge, intellectual conversations, and learning a musical instrument or foreign language can all help build those vital neurons.

(See “Live and Learn: The Benefits of Lifelong Learning” and “13 Creative Ways to Learn Something New” to discover how lifelong learning can improve your health and happiness.)

4) Get your z’s.

Along with its myriad benefits to physical and mental health, sleep provides your brain a chance to clean itself out and rejuvenate. Experts advise getting seven to eight hours of sleep religiously, especially if you’re over 40. (Good sleep is essential to our health, vitality, and well-being. Unfortunately, it’s also the first thing to go when we’re stressed. Explore our “Why Sleep Matters to Your Health” collection to find dozens of strategies and tips to sleep well and reclaim your health.)

5) Protect your vision.

A study of 16,690 adults aged 50 and older, published in JAMA Neurology in 2022, suggests that eyesight impairment could be a key, modifiable factor. Regular eye exams are more important as you age, helping to protect your vision by catching eye diseases and conditions early.

Wear sunglasses outdoors even on cloudy days to block UVA and UVB radiation. And give your eyes a rest every 20 minutes or so when looking at a computer or tablet (see “5 Ways to Ease Digital Eyestrain” for additional tips). An estimated 1.8 percent (more than 100,000 people) of all U.S. dementia cases “could potentially have been prevented through healthy vision,” study authors write.

And a 2021 University of Washington study published in JAMA Internal Medicine found that participants who underwent cataract surgery lowered their risk of dementia by 29 percent compared with those who avoided the procedure. (See “The Cognitive Benefits of Cataract Surgery” for more.)

6) Maintain your hearing.

In its 2020 report, the Lancet Commission on Dementia Prevention, Intervention, and Care ranks hearing impairment, which is defined by the National Institutes of Health as a hearing loss of more than 40 decibels, as a top concern. A 2019 study in JAMA Otolaryngology reviewed the cognitive effects of hearing loss on 6,451 older adults and concluded that every 10-decibel reduction in hearing resulted in reduced cognition.

The Lancet’s report encourages the use of hearing aids as a preventive measure to reduce the risk of associated dementia. As of October 2022, hearing aids are available over the counter in the United States. (For more, enjoy this podcast from Life Time Talks, “Listen Up: Why Taking Care of Your Hearing Health Matters.”)

7) Prevent head injuries.

The 2020 Lancet report warns that concussions and traumatic brain injuries increase dementia risk. Wear a helmet when bicycling, motorcycling, or horseback riding. And if you’re in an accident where you may have hit or even jostled your head, get checked out by a medical professional.

And remember, you don’t actually have to hit your head to get a concussion: one can result from whiplash, or even from the shock waves of an explosion.

Research uncovering the brain’s neuroplasticity — the ability of the brain to grow and adapt throughout our lives — has led to progressive therapies for treatment. (For more on treating head injuries, see “How to Treat Postconcussion Syndrome.”)

8) Limit alcohol use.

It’s long been known that heavy drinking is associated with cognitive impairment and dementia. The Centers for Disease Control and Prevention defines “moderate drinking” as no more than two drinks a day for men and one per day for women.

But some new research is challenging the notion that alcohol offers any benefits for health. The Lancet report states, “Decreasing harmful alcohol drinking could potentially reduce young-onset and later-life dementia.”

9) Breathe well.

Exposure to air pollution — including from first- or second-hand tobacco smoke — can contribute to the onset of dementia, the Lancet report states. “Stopping smoking, even in later life, ameliorates this risk,” the authors advise. (For more, see “Can Air Pollution Affect Your IQ?”)

Alzheimer’s is a disease that develops gradually over many years, Perlmutter explains, and this underscores the importance of prevention long before the first symptoms show up.

“Now that we are secure in the science underpinning the central role of metabolic abnormalities in terms of Alzheimer’s causation, and understand that these changes presage the noticeable changes in cognition by decades, it is mandatory that we do everything to maintain our best metabolism through our lifestyle choices early in our lives,” Perlmutter says before quoting John F. Kennedy’s maxim: “The time to repair the roof is when the sun is shining.”

Explore the brain health collection

The post What Can I Do to Lower My Alzheimer’s Risk and Dementia? appeared first on Experience Life.

]]>
illio of a woman's face with brain neurons
PUMPING IRONY: For Seniors Seeking an Alzheimer’s Diagnosis, Location Matters https://experiencelife.lifetime.life/article/pumping-irony-for-seniors-seeking-an-alzheimers-diagnosis-location-matters/ Tue, 17 Sep 2024 17:00:43 +0000 https://experiencelife.lifetime.life/?post_type=article&p=104854 In the latest evidence of widespread inequities in our healthcare system, researchers have found that dementia sufferers are about twice as likely to get a diagnosis in certain regions of the country than in others.

The post PUMPING IRONY: For Seniors Seeking an Alzheimer’s Diagnosis, Location Matters appeared first on Experience Life.

]]>

Nobody I know seems to be pining for an Alzheimer’s diagnosis, so I didn’t know quite what to think when I came across a study the other day highlighting the regions of the United States in which dementia sufferers were most likely to get one and where they’re harder to come by. At first glance, it struck me as a rather grim version of those emails that land in my inbox from time to time listing the best cities for ordering pizza after midnight or something of that sort.

Upon further review, however, I caught a glimpse of the latest example of our country’s yawning gaps in healthcare services.

The study, published in the journal Alzheimer’s & Dementia, found that someone displaying Alzheimer’s symptoms was about twice as likely to receive a diagnosis of the disease in some regions of the country than in others — even after accounting for regional differences in demographics, education, health, and general diagnostic patterns among healthcare providers.

“These findings go beyond demographic and population-level differences in risk and indicate that there are health system–level differences that could be targeted and remediated,” University of Michigan geriatrician and lead study author Julie Bynum, MD, MPH, explains in a statement. “The message is clear: From place to place the likelihood of getting your dementia diagnosed varies, and that may happen because of everything from practice norms for healthcare providers to individual patients’ knowledge and care-seeking behavior.”

Using Medicare claims filed at 306 hospital referral regions across the country, Bynum and her team analyzed Alzheimer’s diagnoses among some 4.8 million seniors in 2019. They found 143,029 members of that group, or about 3 percent, were diagnosed with the disease in 2019; another 356,656, more than 7 percent, had been diagnosed earlier.

But diagnostic rates varied widely, depending on the region: They found the percentage of seniors diagnosed in 2019 ranged from a low of 1.7 percent in some locales to as high as 5.4 percent in others; previous diagnoses varied from 4 percent in some regions to 14 percent in others.

Accounting for various demographic and lifestyle factors, researchers calculated the “diagnostic intensity” of each region and concluded that patients in the lowest-intensity regions were about 28 percent less likely to receive an Alzheimer’s diagnosis compared with the national average, while those in the highest-intensity areas were about 36 percent more likely to have their dementia symptoms confirmed.

Among those who were generally less apt to receive a diagnosis, Bynum notes, were younger Medicare beneficiaries (ages 66 to 74) as well as Black and Hispanic seniors. This could be attributed to various factors, including healthcare access issues and an individual’s willingness to seek whatever care is available.

Somewhat surprisingly, Bynum and her crew found the lowest-intensity regions were not necessarily concentrated in the so-called “stroke belt” of the southern states, a region long-known for high levels of dementia. It seems that it’s not about the prevalence of the illness as much as the availability of healthcare. Major population centers — throughout the South and nationwide — generally offer patients the best chance of a diagnosis, they concluded, while rural regions tend to offer less-reliable access to diagnostic specialists.

“Our study demonstrates that taking all these factors into account, there remains substantial geographic difference in the likelihood of being diagnosed with [Alzheimer’s],” Bynum concludes, “and that the variation does not follow the ‘stroke belt,’ thereby strengthening the conclusion that the [Alzheimer’s] diagnosis intensity measure is not merely capturing underlying differences in population risk.”

She argues that her findings should be a “call to action for spreading knowledge and increasing efforts to make services available to people.” So, I guess I should feel fortunate to reside in one of those metro areas where there are plenty of dementia specialists available to deliver a diagnosis, should my cognitive function decline more precipitously than normal.

But I can’t help but flinch at the futility of seeking an Alzheimer’s verdict when no reliable — or cost-effective — treatment options are available. I understand that a diagnosis at least allows the patient and their loved ones to access further tests and whatever specialized care happens to be available at the time, but with no cure in sight, it still feels kind of pointless. Like trying to order a pizza after midnight.

The post PUMPING IRONY: For Seniors Seeking an Alzheimer’s Diagnosis, Location Matters appeared first on Experience Life.

]]>
puzzle pieces, a map, and silhouette of a head
Can Fish Oil Supplements Help Moderate the Inflammation Response? https://experiencelife.lifetime.life/article/can-fish-oil-supplements-help-moderate-the-inflammation-response/ Mon, 19 Aug 2024 13:00:43 +0000 https://experiencelife.lifetime.life/?post_type=article&p=103583 The role of omega-3s in managing chronic inflammation and promoting long-term health.

The post Can Fish Oil Supplements Help Moderate the Inflammation Response? appeared first on Experience Life.

]]>

A high-quality fish oil rich in omega-3s is often one of the top supplements encouraged by experts because of the nutrient’s proven role in supporting heart health, brain function, fat loss, and much more.

All the more reason to understand why and how this essential fatty acid — “essential” because our bodies can’t produce it on their own, so we have to get it through our diets — influence the body’s inflammatory response system.

What Is Inflammation?

Inflammation is a natural response from the body’s immune system. In some cases, it can be acute, and the body needs it as part of the natural healing process for injury or infection — think a sprained ankle or the redness from a scrape or cut on the skin. This type of inflammation is positive, says Gregory Plotnikoff, MD, a board-certified internist and pediatrician and founder and medical director of Minnesota Personalized Medicine. Though it may be uncomfortable, it aids in recovery and healing.

In an episode of Life Time Talks, Plotnikoff shares that it’s when inflammation becomes chronic and systemic that it becomes more harmful and can contribute to many of the chronic illnesses that we want to avoid. “To stay as healthy as possible, it means attentiveness to things that could drive inflammation,” he says.

As reported in Experience Life, weight-loss resistance, brain fog, anxiety and depression, fatigue, gut dysfunction, joint pain, and headaches can all be signs of ongoing inflammation in the body. It can also show up via conditions like rheumatoid arthritis, inflammatory bowel disease, or lupus.

And sometimes, it can be invisible, as Shilpa Ravella, MD, Columbia University Irving Medical Center assistant professor and author of A Silent Fire: The Story of Inflammation, Diet, and Disease, shares with Experience Life.

Cassie Wilder, NMD, founder of the Minneapolis Integrative Medicine Center, also notes that chronic inflammation can be caused by a continuous trigger (such as polluted air, excess visceral fat, or a disrupted gut microbiome) or if the body is lacking the resources it needs to quell inflammation (such as if your immune system isn’t operating optimally due to factors like chronic stress, poor sleep, or an unhealthy diet). Or, she says, these two causes can work in combination.

Linked to numerous health problems, including heart disease, mood disorders, diabetes, cancer, multiple sclerosis, and Alzheimer’s, chronic inflammation can significantly impair quality of life and longevity. (Learn more: “What Is Inflammation?” and “How Chronic Inflammation Affects Your Health.”)

How Fish Oil Supplements Can Modulate Inflammation

Fish oil supplements can play a crucial role in helping to manage the inflammation processes throughout the body. Made up of omega-3 fatty acids, a quality fish oil supplement contains concentrated doses of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), the most active forms of omega-3s.

“EPA and DHA are long-chain fatty acids that are critical for healthy cell membrane function,” says Paul Kriegler, RD, CPT, director of nutritional product development at Life Time. “In addition to being the structural components of cell membranes, they have roles as signaling molecules to promote healthy inflammatory response to injury or infection. Some evidence suggests omega-3s are also capable of boosting adaptive immune response.”

In another Experience Life article, Life Time Health experts also share that, “The endocannabinoid system regulates inflammation. DHA and EPA can be metabolized into cannabinoids, making these omega-3s important for the function of your endocannabinoid system.”

While the best dietary sources of EPA and DHA are fatty fish — salmon, mackerel, or sardines, for example — most people do not eat enough to obtain optimal levels of omega-3s. A study in Nutrition Journal reported that the average person’s fish intake is less than half the recommended amount established by the American Heart Association, which is at least two 3.5-ounce servings of fatty fish per week.

That recommendation is below what the team of Life Time dietitians advise for dietarily supporting omega-3 levels, which is at least an 8- to 10-ounce portion at minimum three times per week.

“Supplementing with high-quality fish oil is a safe and effective way to address this nutritional gap,” says Kriegler.

Fish oil also reliably counteracts pro-inflammatory omega-6s, which are abundant in highly processed foods and refined cooking oils. When omega-3s and omega-6s are represented more or less equally in the body, according to Experience Life’s reporting, they complement each other, governing the immune system and aiding in the production of prostaglandins, the hormones that regulate inflammation.

But according to numerous studies reviewed by the Journal of Nutrition and Metabolism, an increased ratio of omega-6s to omega-3s — and an overall rise in omega-6 consumption — damages important mediators and regulators of our inflammation and immune responses.

Incorporating a quality fish oil supplement into your routine can help restore this stability and mitigate the risks of chronic inflammation. (Learn more: “Fish Oil: Health Benefits of Supplementing for Your Body and Brain.”)

The post Can Fish Oil Supplements Help Moderate the Inflammation Response? appeared first on Experience Life.

]]>
A number of fish oil capsules.
PUMPING IRONY: Banking on the Bucolic Brain https://experiencelife.lifetime.life/article/pumping-irony-banking-on-the-bucolic-brain/ Wed, 14 Aug 2024 17:00:11 +0000 https://experiencelife.lifetime.life/?post_type=article&p=103078 A new study suggests that living amid more “residential greenery” during midlife may delay the onset of Alzheimer’s — even among those genetically predisposed to the disease. If memory serves, I may be one of the lucky ones. Or maybe not.

The post PUMPING IRONY: Banking on the Bucolic Brain appeared first on Experience Life.

]]>

Even quasi-hopeful news is a rarity on the Alzheimer’s front these days, what with the variety of risk factors rising and Big Pharma as vexed as the rest of us, so I had to smile last week when I happened upon research suggesting that all we have to do to slow the onslaught of dementia is live among the trees.

Researchers at the Boston University School of Public Health aren’t recommending we abandon the comforts of modern life for a cabin in the woods, but they do offer some intriguing evidence that those who happen to reside in midlife among more “residential greenery” — parks and woods and the like —tend to suffer cognitive decline at a slower rate than their counterparts living in less bucolic surroundings.

The benefits were particularly notable for people living among greenery in poorer neighborhoods and among those most genetically predisposed to developing Alzheimer’s. Cognitive decline among carriers of the dreaded APOE4 gene living in greener locales occurred even more slowly than those who did not carry the gene, researchers found. And because the disease typically begins to develop decades before symptoms appear, they believe their findings could guide people to take protective measures long before the disease takes hold.

“Our results are important because they shed light into the cognitive benefits of increasing green-space exposure at a population level, particularly among vulnerable subgroups of the population,” explains lead study author Marcia Pescador Jimenez, PhD, an assistant professor of epidemiology, in a statement released by the university.

She and her team analyzed geographic and cognitive data from the Nurses’ Health Study involving nearly 17,000 people 70 years old and older between 1995 and 2008. They used a satellite-image metric to assess green space around each participant’s home nine years prior to conducting a series of cognitive tests for each individual during the following six years.

Researchers estimated that residing among sufficient greenery may slow an individual’s annual rate of cognitive decline by about eight months.

The results, published in the journal Environmental Health Perspectives, build on earlier, smaller studies showing an association between access to green space and improved mental health. Boost your mental health, research has shown, and you’re less likely to descend into dementia. “Greenness has been consistently linked to lower levels of depression,” Pescador Jimenez writes. “In addition, depression has been documented to be an important modifiable risk factor of dementia.”

So, just as giving up smoking or lowering your blood pressure or cutting back on your alcohol consumption may help you delay — or avoid altogether — the onset of Alzheimer’s, Pescador Jimenez and her colleagues believe settling into lush surroundings may also do the trick.

More research is needed, of course, so before you consider pulling up stakes and relocating to more bucolic terrain, you might note that researchers did not take into account factors such as neighborhood amenities and crime rate, or to what extent participants actually spent time in nearby parks and other green spaces.

“We acknowledge that it is potentially possible that reverse causation explains some of the effects observed,” she admits.

Still, I’ll take any signs of hope I can find in my quest to delay what sometimes seems an inevitable descent into some degree of absentmindedness. I seem to recall, for instance, that My Lovely Wife and I moved our family when we were in our 40s from a mostly concrete landscape to what by comparison seemed like an arboreal paradise. That should count for something, right?

If I remember correctly, we even planted some shrubs.

The post PUMPING IRONY: Banking on the Bucolic Brain appeared first on Experience Life.

]]>
a beautiful sunlit park path lined with trees
Listen Up: Why Taking Care of Your Hearing Health Matters https://experiencelife.lifetime.life/podcast/listen-up-why-taking-care-of-your-hearing-health-matters/ Tue, 23 Jul 2024 10:00:57 +0000 https://experiencelife.lifetime.life/?post_type=podcast&p=101622 The post Listen Up: Why Taking Care of Your Hearing Health Matters appeared first on Experience Life.

]]>

The post Listen Up: Why Taking Care of Your Hearing Health Matters appeared first on Experience Life.

]]>
heidi headshot and man holding ear
PUMPING IRONY: On the Alzheimer’s Frontier, Big Pharma Plays Regulatory Roulette https://experiencelife.lifetime.life/article/pumping-irony-on-the-alzheimers-frontier-big-pharma-plays-regulatory-roulette/ Wed, 12 Jun 2024 20:23:34 +0000 https://experiencelife.lifetime.life/?post_type=article&p=100036 New research suggests that we may be closer than ever to understanding a cause of Alzheimer’s. Will a suddenly more scrupulous Food and Drug Administration give serious consideration to novel treatment options?

The post PUMPING IRONY: On the Alzheimer’s Frontier, Big Pharma Plays Regulatory Roulette appeared first on Experience Life.

]]>

I suppose you could call it ironic that researchers seem finally to be homing in on a potential cause of Alzheimer’s at a time when our chief regulatory agency is becoming more skeptical of potential remedies. Call it what you will, but I suspect recent developments on the dementia frontier will likely leave physicians and their cognitively challenged patients more vexed than hopeful.

Scientists in Spain last month released the results of a study suggesting that a certain gene long thought to be merely a risk factor for the disease may actually cause the illness. As Pam Belluck reports in the New York Times, the findings indicate that hundreds of thousands of Americans could be treated for Alzheimer’s well before showing any signs of cognitive dysfunction. Big Pharma, meanwhile, could respond by expanding its current scope of research, focusing more intently on gene therapy, for instance, rather than its current fixation on brain plaque.

“This reconceptualization that we’re proposing affects not a small minority of people,” lead study author Juan Fortea, PhD, tells Belluck. He estimates that about 15 to 20 percent of all Alzheimer’s cases “can be tracked back to a cause, and the cause is in the genes.”

People carrying two copies of the gene variant APOE-ε4 have generally been considered vastly more likely than those without the gene to develop Alzheimer’s, so Fortea, director of the Saint Pau Memory Unit in Barcelona, and his team analyzed data from more than 500 subjects fitting that profile and found almost all of them had developed a key biological marker of the disease — an accumulation of amyloid plaque on the brain — by the age of 55.

That means the disease could be well advanced by the time doctors are able to make a diagnosis and suggest treatment options, notes study coauthor Reisa Sperling, MD, a neurologist at Mass General Brigham Hospital in Boston. “The critical thing is that these individuals are often symptomatic 10 years” before they’re diagnosed with Alzheimer’s disease, she says.

These APOE-ε4 carriers are also more likely to suffer from brain swelling and bleeding when treated with the Alzheimer’s drug currently on the market, a fact that leads some experts to argue that Fortea’s study should inspire drug companies to include this cohort in trials focusing on safer, more effective medications. Some scientists are already searching for gene-editing options that would transform the more dangerous variant to its APOE-ε2 cousin, which has shown signs of protecting the brain against plaque accumulation, Belluck reports. Other researchers are exploring the potential of injecting APOE-ε2 into the brains of Alzheimer’s patients.

Whether such exotic remedies would pass muster at our suddenly scrupulous Food and Drug Administration (FDA), however, is another question altogether.

On Monday, a full 364 days after Eli Lilly submitted its application for approval of its Alzheimer’s drug donanemab, an FDA advisory panel convened to make its recommendation. And if preliminary reports are any indication, the Big Pharma giant is likely to face some tough questions.

The FDA back in March notified Lilly that it was delaying action on the drugmaker’s application as it sought to get more clarity on the drug’s safety and efficacy as well as its trial design. The move caught the company by surprise. “We were not expecting this,” Lilly executive vice president Anne White told the Times. It was unusual to make such a move “at the end of the review cycle and beyond the action date that the FDA had given us.”

But the agency was still reeling from its controversial accelerated approval in 2021 of Biogen’s initial entry into the Alzheimer’s sweepstake, aduhelm. The FDA’s ruling came despite almost unanimous disagreement from its advisory panel, and the well-documented controversy — along with the drug’s price and questions about its safety and efficacy — swiftly dampened demand. The company withdrew it from the market earlier this year.

In the months since the aduhelm controversy, the agency has approved one other Alzheimer’s drug, Leqembi, while managing to sidestep further turmoil, and the Lilly decision seems to reflect a more cautious approach. In documents released last week, agency scientists revealed various concerns, including whether donanemab treatments should be limited to patients whose brains have accumulated deposits of tau, a toxic protein. They also encouraged the panel to determine the risks of brain swelling and what criteria would be used to consider ending a patient’s treatment.

This level of oversight does not disqualify Lilly’s drug; the FDA panel on Tuesday determined that donanemab’s benefits outweighed its risks. It does, however, seem to indicate that it will be some time before we’ll be able to head to our local clinic for an APOE-ε2 brain injection when we’re feeling a little absent-minded. I suspect that won’t prevent the more curious among us from surveying their genetic makeup hoping to learn whether they’re carrying the APOE-ε4 variant, but Stanford University neurologist Michael Greicius, MD, MPH, counsels against such an exploration.

Fortea’s study, he argues, was limited by a lack of ethnic diversity among its participants, making it more difficult to generalize its results. “One important argument against their interpretations is that risk of Alzheimer’s disease in APOE-ε4 homozygotes varies substantially across different genetic ancestries,” he explains. “This has critical implications when counseling patients about their ancestry-informed genetic risk for Alzheimer’s disease, and it also speaks to some yet-to-be-discovered genetics and biology that presumably drive this massive difference in risk.”

Besides, with no reliable treatment options for those who have lost the genetic lottery, such knowledge offers few benefits. “My recommendation is if you don’t have symptoms, you should definitely not figure out your APOE status,” he says. “It will only cause grief at this point.”

The post PUMPING IRONY: On the Alzheimer’s Frontier, Big Pharma Plays Regulatory Roulette appeared first on Experience Life.

]]>
illustration of brain with puzzle piece
How to Share a Difficult Diagnosis https://experiencelife.lifetime.life/article/how-to-share-a-difficult-diagnosis/ https://experiencelife.lifetime.life/article/how-to-share-a-difficult-diagnosis/#view_comments Wed, 13 Mar 2024 12:00:44 +0000 https://experiencelife.lifetime.life/?post_type=article&p=90192 The decision to disclose an illness to others is often a complicated one. This guidance can help you share the news your way.

The post How to Share a Difficult Diagnosis appeared first on Experience Life.

]]>

The moment I noticed a voicemail from my friend Alice, I knew something was wrong. We’re texters, not callers. I left my date alone at the bar and slipped outside, where I listened to her message. “I don’t know how to tell you this,” Alice said, her voice shaking, “but Chloe is dead.”

Chloe was my Alexander Technique teacher. I’d started sessions with her a few years earlier, when my doctor suggested that she might be able to help ease the debilitating pain I’d been feeling in my hands: a repetitive strain injury that comes with my work as a writer and editor. I’d meet her for appointments in her converted studio apartment, where she’d observe me while I stood and walked around, saying things like “let your knees float” and recommending ways to move my body more comfortably.

I never understood exactly how the Alexander Technique worked, but I knew that it did. After working with Chloe for just a few months, I could use a keyboard again, write with a pen, and clip my own fingernails. And she helped others too, including Alice, who learned of Chloe’s death on what was then Twitter.

Over the coming weeks, we’d find out that Chloe had cancer and that she hadn’t told anyone but her assistant. I was devastated that I hadn’t had the chance to say goodbye and confused about why she had kept her diagnosis a secret. At first, I could only guess at her reasoning. Chloe was so nurturing by nature — maybe she felt she wouldn’t be able to resist the pull of comforting us, thereby depriving herself of the energy she needed to heal. Or perhaps . . . I didn’t know.

Asking Why

I know now, after speaking with several experts, that there are plenty of reasons someone might choose not to share a difficult diagnosis. Many people cite a desire to process the information in their own way, at their own pace.

One person, writing under a pseudonym in a Good Housekeeping article, detailed her reasons for not disclosing her breast-cancer diagnosis at age 47. When her oncologist pushed her to share her situation, saying she’d get more support, she bristled at the suggestion.

“I knew the kind of support my oncologist promised, while well-intentioned and meaningful, would be detrimental to my psyche,” she explains. “Cancer breaks you wide open and I didn’t want people, no matter how beloved, picking apart my ugly innards. Giving everyone a seat at the table where I was waging a war for my life didn’t feel supportive. It felt intrusive.”

You may also worry that sharing the news might irrevocably alter your social relationships, explains Nora McInerny, host of the podcast Terrible, Thanks for Asking and author of It’s Okay to Laugh (Crying Is Cool Too). “I’ve met people who’ve been through all different kinds of situations and losses and diagnoses,” she says, “and the fear I hear often is, ‘If somebody knows this about me, that will be all they see in me. That will redefine my relationship to them.’” (Learn more about McInerny’s story here.)

Or you may simply need more time to make sense of the news yourself, says Neha Sangwan, MD, author of TalkRX and Powered by Me. “If the person is young and knows their runway has been shortened by 50 years, it’s often a very different experience than an 81-year-old who has gone through the gradual decline in function of their body,” Sangwan explains. “How unexpected the diagnosis is to the person combined with their skill in navigating their emotions determines the level of overwhelm and trauma that they’re experiencing. Their level of self-trust and emotional boundaries will likely affect how comfortable they’ll feel sharing the information with others.”

Experience Life staffer Jane Meronuck was 52 when she was diagnosed with a cancer of unknown origin and told she had seven months to live. She shared her diagnosis only with her immediate circle, waiting three months to write a CaringBridge post; she wanted to understand her disease and prognosis more clearly before sharing it with a wider group. (Learn more about Meronuck’s story at “Jane Meronuck’s Success Story.”)

I now have a much better understanding of Chloe’s wordless exit from her students’ lives. I don’t judge her decision; that’s not my place. There’s no right or wrong way to reveal a difficult diagnosis. There’s only the way to do it for you.

How to Share the News On Your Terms

Here are some ways to find an approach that works best for you — and a few strategies for making the process easier.

1) Find a Spokesperson

Nora McInerny had been dating her late husband, Aaron, for a year when he was diagnosed with glioblastoma. He asked her to tell people for him. “I did not know his family that well,” she recalls. “He wanted me to do it because it was too much for him. I am honored that I got to do that, and I was completely unprepared to do that.”

Still, McInerny adds, she could see how much her role as spokesperson helped Aaron, in that it allowed him to focus on healing.

Jane Meronuck’s husband, Chris, filled that communi­cations role for her, she says.

But, because not everyone has a partner, McInerny suggests enlisting a friend, a sibling, or even a care professional to help you disclose your diagnosis to a wider circle. “If you don’t have a Nora, find a Nora,” she advises.

2) Read the Room

Last summer, I found out via text that a friend of mine had died by suicide. On a second occasion, I learned — also via text — that another friend had been murdered. In neither case did the person sending the text ask if I was in the right headspace for that kind of news. Both times, I felt completely blindsided, or what McInerny calls “driveby devastated.”

When you’re considering how to reveal a difficult diagnosis (or how to instruct your spokesperson to do so), McInerny suggests practicing “conversational consent” by making sure it’s the right time and place for the person to receive the information. It can be as simple as saying, “I have something to tell you that’s difficult for me to say, and it might be difficult for you to hear. Is this a good time?”

3) Write a Practice Script

Whomever you choose to tell about your diagnosis — and however you choose to tell them —  writing down some important points ahead of time can help you make sure you don’t forget anything, and it may help calm your nerves when you deliver the news. It can also help you prepare yourself (or your spokesperson) for the inevitable questions. (See “Compassionate Communication” for examples of initiating difficult conversations.)

On that note, expect a range of reactions from your friends and family. Unfortunately, some people won’t react well to distressing news. A few people I spoke to for this article noted that some of the folks they most expected to be pillars of support during their crises actually disappeared — and some found relief and comfort from people they’d previously considered only minor players in their lives.

4) Set Boundaries Beforehand

If you do choose to talk to certain people directly, defining boundaries ahead of the conversation can help avoid potential problems.

If you just want to tell the person but don’t want advice, be sure to make that clear. You can say something like this: “I don’t need you to fix this problem or offer advice, but I need to tell you something.” McInerny adds that this step is especially important in relationships involving people harboring beliefs that differ from yours — whether those beliefs are religious, spiritual, or otherwise.

“When we expect people to just know what we want without explaining it to them,” she says, “it’s setting the relationship up for failure.”

By expressing your needs ahead of time, you’re setting everyone up for success.

5) Use Social Media (or Don’t)

If you want to reach many people at once, social media is a good way to do it. And if you want support from others, many social platforms allow you to connect with people in your specific situation — after all, there are Facebook groups for just about everything.

Meronuck found support through a Facebook group for stage IV cancer patients. “It was invaluable to have access to people who knew firsthand what I was experiencing,” she recalls.

End-of-life doula ­Michelle Kolling, founder of the Minneapolis-based service Held, adds that sharing news via social media allows you to make your desired level of contact clear. “It’s a good way to communicate that you don’t want individual conversations at that time, like ‘We’ll reach out personally as soon as we are able,’” she explains.

You can also clearly state that you’re not looking for treatment advice or describe specifically the kind of support that you do want from your social media circle.

As with all things online, there are pitfalls to avoid. If you want to notify certain people yourself, make sure you’ve told them before posting about it. And get familiar with your privacy settings and your network so you know how far the information is traveling. You might choose to share on a platform that’s limited to people coping with a situation similar to yours — or you might be comfortable notifying a wider group all at once.

But it’s really up to the ­individual. Some people simply don’t use social media, or they don’t enjoy it. There’s no reason to share this sort of news in a specific way just because it’s something other people do. “You’re not obligated to bleed out your personal information, feelings, or details for anybody else’s benefit,” McInerny says. “You aren’t. That is completely up to you.”

6) Get Professional Support

Doulas like Kolling can offer crucial support for people nearing death. They can help you prepare to break the news ­­— if and when you choose to do so — by helping to facilitate difficult conversations or helping you prepare your practice script.

They can also provide nonmedical, practical, emotional, and spiritual support for those facing the end of life — as well as for their loved ones. “We can spend time with the family, to get to know the family dynamics,” Kolling explains. “And we then can focus on the dying person and what is important to them now.”

She’ll often help with letter writing or legacy projects, to offer people a sense that they’ll be remembered and that their lives had meaning.

Few of us feel comfortable talking about death, much less preparing for it, Kolling notes. “Because of advances in the medical field and in healthcare, it’s common to view death as a medical failure instead of a part of life.”

She wants to normalize conversations about dying and what to expect during that process.

Kolling believes what she does is similar to the role of a birth doula, except that she’s facilitating an exit rather than an entrance. “It’s the other end of life. It’s the birth out of this life.”

 Balance

Explore more empowering strategies to support your efforts to live in (closer) alignment with your values at our Balance department.

This article originally appeared as “Sharing a Difficult Diagnosis” in the March/April 2024 issue of Experience Life.

The post How to Share a Difficult Diagnosis appeared first on Experience Life.

]]>
https://experiencelife.lifetime.life/article/how-to-share-a-difficult-diagnosis/feed/ 0 a woman meets with her family to share her recent medical diagnosis